Company pipeline · women's health

ZIWIG women's health pipeline

ZIWIG is the lead sponsor of 3 active trials in the conditions TrialsForHer tracks (Endometriosis), 2 of them open to recruitment now or about to open.

Data pulled 21 Oct 2026Sources: ClinicalTrials.gov + EU CTISAll company pipelines
2open or about to open
3active trials (incl. recruitment ended)
1tracked condition
Dec 2026next registry-reported primary completion (est.)

Trials

Open trials first, then by primary completion date. Phases: N/A (non-drug): 1, Observational: 2. "est." marks the sponsor's estimated date; CTIS search results don't include primary completion dates.

IDTitleConditionLead sponsorPhaseStatusPrimary completionEnrolmentSite countries
NCT06392997
ClinicalTrials.gov
Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic PathologyEndometriosisZIWIGObservationalRecruitingDec 2026 (est.)2,500France
NCT07560852
ClinicalTrials.gov
Impact of Endotest on Patients' Quality of Life: a Cohort StudyEndometriosisZIWIGObservationalRecruiting31 Jul 2029 (est.)20,000France
NCT06794424
ClinicalTrials.gov
Impact of Ziwig Endotest® on the Management of Patients With Clinical Symptoms of Endometriosis Inconsistent With Their Imaging Work-upEndometriosisZIWIGN/A (non-drug)Active, not recruiting1 Sep 2026 (est.)2,503France

See also: upcoming women's-health trial readouts · Endometriosis trials · PCOS trials · Menopause trials

Want biotech news too? Closewire: nightly recap of what moved in Tech and Health stocks, plus a free Sunday weekly. Subscribe to Closewire →
Business research data, not medical advice. TrialsForHer summarises public registry records from ClinicalTrials.gov and the EU Clinical Trials Information System (CTIS) for professional and research use. Registry entries can be incomplete or out of date, and dates marked "est." are the sponsor's own estimates. Always check the official record. This isn't a way to enrol in a study; patients and carers should talk to their clinician or the study team listed on the registry.